[Stereotactic body radiotherapy in liver tumors]

Larrea Bonavento N, Augustovski F, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A.
Record ID 32018001479
Original Title: Radioterapia corporal estereotáxica en tumores hepáticos
Authors' recomendations: CONCLUSIONS Low-quality evidence suggests contradictory results for stereotactic body radiotherapy effectiveness in patients with primary or metastatic liver tumors versus other therapeutic options. Some clinical practice guidelines assessed consider stereotactic body radiotherapy as an alternative to other existing techniques (radiofrequency, transarterial chemoembolization, other types of radiotherapy, etc.) for the treatment of local liver tumors, while others only consider it for patients who are not candidates or have contraindications for other therapies. Of the coverage policies assessed, only some United States private health sponsor cover stereotactic body radiotherapy for eligible patients. No cost-effectiveness studies or budgetary-impact analysis have been found in Argentina.
Project Status: Completed
Year Published: 2018
URL for published report: https://www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Liver Neoplasms
  • Radiosurgery
  • Radiotherapy
  • Carcinoma, Hepatocellular
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.